
IndieBio is a biotech startup accelerator operated by SOSV, providing pre-seed funding, lab space, and mentorship to early-stage life sciences and synthetic biology startups. Founded in 2014 in San Francisco, it was the world's first accelerator dedicated to synthetic biology.
36% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $8.9M (across 10 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Unknown | $2.1M | Mar 2024 | |
| Unknown | $2.1M | Jan 2024 | |
| Seed | $6.4M | Feb 2023 | |
| Pre-Seed | — | Jan 2023 | |
| Seed | $2.5M | Nov 2022 | |
| JJoywell Foods | Series B | $25M | May 2022 |
| Series A | $36M | May 2022 | |
| BBeeflow | Series A | $8.3M | Jun 2021 |
| AAllied Microbiota | Seed | $1.2M | Oct 2020 |
| Seed | $3M | — | |
| IiOrganBio | Unknown | $2M | — |
Top Co-Investors
Plug and Play Tech Center2 shared
Fen Ventures2 shared
Alumni Ventures1 shared
Khosla Ventures1 shared
Viola Ventures1 shared
B371 shared
Global Brain Corporation1 shared
Piva Capital1 shared
UBS1 shared
Horizons Ventures1 shared
Level One Fund1 shared
Social Impact Capital1 shared
Siddhi Capital1 shared
KAPITAL1 shared
CJ CheilJedang1 shared
Bek Ventures1 shared
Mouro Capital1 shared
Ospraie Ag Science1 shared
Grid Exponential1 shared
Future Fund1 shared
Last updated: 8 September 2026